Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion

Retinal vein occlusion is one of the most severe vascular lesions of the organ of vision, usually accompanied by somatic pathology.The aim of the study was to study the somatic status and individual biochemical markers in patients with retinal vein occlusion and comparison in groups opposing the eff...

Full description

Bibliographic Details
Main Authors:	I. V. Zlobin, T. N. Iureva, Yu. V. Kursakova
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2019-08-01
Series:	Acta Biomedica Scientifica
Subjects:	retinal vein occlusion somatic status arterial hypertension anti-vegf therapy ranibizumab
Online Access:	https://www.actabiomedica.ru/jour/article/view/2138

Similar Items

Retinal vein occlusion
by: Hayreh Sohan
Published: (1994-01-01)

Efficacy of first Ranibizumab intravitreal injection on macular edema caused by retinal vein occlusion
by: Hong Cao, et al.
Published: (2015-09-01)

A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
by: Shashikant Sharma, et al.
Published: (2020-07-01)

Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
by: Vasileios E. Konidaris, et al.
Published: (2018-10-01)

Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion in a Real Life Practice: A Retrospective Case Series
by: Abdullah Ozkaya, et al.
Published: (2016-12-01)

PREVALENCE OF HYPERHOMOCYSTEINEMIA IN PATIENTS WITH RETINAL VEIN OCCLUSION
by: M. R. Shoja M. R. Besharaty, et al.
Published: (2006-11-01)

PREVALENCE OF HYPERHOMOCYSTEINEMIA IN PATIENTS WITH RETINAL VEIN OCCLUSION
by: M. R. Manaviat, et al.
Published: (2006-12-01)

Axial Length in Retinal Vein Occlusion
by: MirNaghi Mousavi, et al.
Published: (2015-01-01)

Alterations in Retinal Vessel Diameters in Patients with Retinal Vein Occlusion before and after Treatment with Intravitreal Ranibizumab
by: Evaggelia Aissopou, et al.
Published: (2023-02-01)

Central retinal vein occlusion caused by anomalous prepapillary venous loop
by: Pradeep Gajanan Tekade, et al.
Published: (2021-01-01)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
by: Callizo J, et al.
Published: (2019-11-01)

Anti-VEGF combined with retinal laser in treatment of retinal vein occlusion with macular edema
by: Yu-Lun Ou, et al.
Published: (2019-07-01)

Relationship Between Retinal Vein Occlusion and Axial Length
by: San-Chang Tsai, et al.
Published: (2003-09-01)

Dexamethasone implant in retinal vein occlusions
by: Han SB, et al.
Published: (2016-08-01)

Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Cataract Surgery Is Not Associated with Decreased Risk of Retinal Vein Occlusion
by: Yelena Bagdasarova, PhD, et al.
Published: (2021-09-01)

Efficacy and prognostic factors of Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Zhi-Jun Shen, et al.
Published: (2022-10-01)

Foveal Thickness Fluctuations in Anti-VEGF Treatment for Central Retinal Vein Occlusion
by: Daisuke Nagasato, MD, PhD, et al.
Published: (2024-03-01)

Central Retinal Vein Occlusion Associated with Fibromuscular Dysplasia: A Case Report
by: Emma Astrike-Davis, et al.
Published: (2022-03-01)

Combined central retinal artery and vein occlusion following trabeculectomy
by: Bromeo, Albert John, et al.
Published: (2022-06-01)

Effects of different does intravitreous triamcinolone acetonide for macular edema secondary to retinal vein occlusion
by: Jing Su, et al.
Published: (2018-08-01)

Neovascular events in eyes with central retinal vein occlusion undergoing serial bevacizumab or ranibizumab intravitreal injections: A retrospective review
by: Francis Char DeCroos, et al.
Published: (2014-01-01)

Potential Prognostic Indicators for Patients With Retinal Vein Occlusion
by: Shan Yin, et al.
Published: (2022-05-01)

Therapeutic effects of intravitreal implantation of Dexamethasone and Ranibizumab in the treatment of retinal vein occlusion
by: Lei Shen, et al.
Published: (2022-12-01)

The Major Role of Anti-Vascular Endothelial Growth Factor for Management of Macular Edema Secondary to Retinal Vein Occlusion
by: Hossam Elden Mohamed Ahmed Khalil, et al.
Published: (2021-06-01)

Report of intravitreal injection of Ranibizumab for macular edema caused by central retinal vein occlusion
by: Jing-Yi Lai, et al.
Published: (2016-04-01)

Management of Retinal Vein Occlusion, Who Is Responsible?
by: Mohamadreza Aghamirsalim, et al.
Published: (2016-12-01)

Systematic evaluation of the efficacy of Conbercept and Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Man Yu, et al.
Published: (2020-12-01)

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
by: Taro Otawa, et al.
Published: (2022-06-01)

Microvascular comparison in younger and older patients with retinal vein occlusion analyzed by OCT angiography
by: Panpan Ye, et al.
Published: (2021-04-01)

Multifocal electroretinogram changes in patients with retinal vein occlusion
by: Heba M Shafik, et al.
Published: (2020-01-01)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
by: Kawamura M, et al.
Published: (2018-08-01)

Effects of intravitreal injection of ranibizumab and aflibercept for branch retinal vein occlusion on the choroid: a retrospective study
by: Shuta Kishishita, et al.
Published: (2022-11-01)

Comparison between intravitreal Ranibizumab and Tramicinolone acetonide for macular edema secondary to central retinal vein occlusion
by: Miao Zeng, et al.
Published: (2014-08-01)

Role of the Hereditary Thrombophilic Abnormalities in Retinal Vein Occlusion
by: Handan Canan, et al.
Published: (2015-12-01)

A rare case report of branch retinal vein occlusion in a COVID-19-positive patient
by: Pradeep Kumar Panigrahi
Published: (2022-01-01)

Efficacy and safety of Ziv-aflibercept in patients with central retinal vein occlusion
by: Amin E Nawar, et al.
Published: (2021-01-01)

Ranibizumab versus aflibercept for macular edema secondary to nonischemic central retinal vein occlusion in young adult patients
by: Ahmed A Amer, et al.
Published: (2022-01-01)

Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy
by: Andrey G Shchuko, et al.
Published: (2015-01-01)

Combined branch retinal vein and branch retinal artery occlusion – clinical features, systemic associations, and outcomes
by: Sabyasachi Sengupta, et al.
Published: (2017-01-01)